Targeted therapies: STAT3 and EGFR target resistance

Nature Reviews Clinical Oncology

Volumn 9, Issue 9, 2012, Pages 489-

  Kirk, Rebecca ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; STAT3 PROTEIN;

ENZYME ACTIVATION; ENZYME ACTIVITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

EID: 84865692047     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2012.140     Document Type: Note

References (1)

1. Original article Grandis, J. R. et al. Targeting STAT3 abrogates EGFR inhibitor resistance in cancer. Clin. Cancer Res. doi:10-1158/1078-0432. CCR-12-0792